Bacterial protein toxins as biological weapons

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2006, Pages 1019-1030

  Smith, Leonard A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76349114323     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088445-2/50067-6     Document Type: Chapter

References (141)

1. Adak G.K., Long S.M., O'Brien S.J. Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut 2002, 51:832-841.
2. Alibek K., Handleman S. Biohazard 1999, Random House, New York.
3. Arnon S.A., Schecter R., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Hauer J., Layton M., Lillibridge S., Osterholm M.T., O'Toole T., Parker G., Perl T.M., Russell P.K., Swerdlow D.L., Tonat K. Botulinum toxin as a biological weapon. JAMA 2001, 285:1059-1070.
4. Aureli P., Fenicia L., Pasolini B., Gianfranceschi M., McCroskey L.M., Hatheway C.L. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J. Infect. Dis. 1986, 154:207-211.
5. Balaban N., Rasooly A. Staphylococcal enterotoxins. Int. J. Food Microbiol. 2000, 61:1-10.
6. Ball A.P., Hopkinson R.B., Farrell I.D., Hutchison J.G.P., Paul R., Watson R.D.S., Page A.J., Parker R., Edwards C.W., Snow M., Scott D.K., Leone-Ganado A., Hastings A., Ghosh A.C., Gilbert R.J. Human botulism caused by Clostridium botulinum type E: The Birmingham outbreak. Quart. J. Med. 1979, 48:473-491.
7. Barnaby W. The Plague Makers: The Secret World of Biological Warfare 1997, 5-20. Satin Publications Limited, New York, N.Y.
8. Bernstein B.J. The birth of the U.S. biological warfare program. Sci Am. 1987, 256:116-121.
9. Bernstein B.J. Origins of the U.S. biological warfare program. Preventing a Biological Arms Race 1990, 9-25. Chapter 1, The MIT Press, London. S. Wright (Ed.).
10. Blik H. Disarming Iraq 2004, 67. Pantheon Books, Cambridge, MA.
11. Blik H. Disarming Iraq 2004, 256-257. Pantheon Books, New York, N.Y.
12. Bozheyeva G., Kunakbayev Y., Yeleukenov D. Former Soviet Biological Weapons Facilities in Kazakhstan: Past, Present, and Future. Occasional paper No. 1 1999, 1-20. Center for Nonproliferation Studies, Monterey Institute of International Studies, New York, N.Y.
13. Bryden J. Deadly Allies: Canada's Secret War, 1937-1947 1989, McClelland & Stewart, Monterey, CA.
14. Butler R. The Greatest Threat: Iraq, Weapons of Mass Destruction and the Crisis of Global Security 2000, 86-88. Public Affairs, Toronto, Ontario.
15. Cartwright F.F. Disease and History 1974, 124-125. New American Library, New York, N.Y.
16. Carus W.S. The Rajneeshees (1984). Toxic Terror: Assessing Terrorist Use of Chemical and Biological Weapons 2000, 115-137. Chapter 8, MIT Press, New York, N.Y. J.B. Tucker (Ed.).
17. Carus W.S. Working Paper Bioterrorism and Biocrimes: The Illicit Use of Biological Agents Since 1900 2001, Center for Counterproliferation Research, National Defense University, Cambridge, MA.
18. Caudle L.C. The biological warfare threat. Textbook of Military Medicine, Part I: Warfare, Weaponry, and then Casualty: Medical Aspects of Chemical and Biological Warfare 1997, 451-466. Chapter 21, Borden Institute, Walter Reed Army Medical Center, Washington, D.C. F.R. Slidell, E.T. Takafuji, D.R. Franz (Eds.).
19. Centers for Disease Control and Prevention Botulism in the United States, 1899-1998. Handbook for epidemiologists, clinicians, and laboratory workers 1998, U.S. Department of Health and Human Services, Public Health Service, Washington, D.C.
20. Christopher G.W., Cieslak T.J., Pavlin J.A., Eitzen E.M. Biological warfare: a historical perspective. JAMA 1997, 278:412-417.
21. Cochrane R.C. Biological Warfare Research in the United States. History of the Chemical Warfare Service in World War II (01 July 1940-15 August 1945) 1947, Historical Section, Plans, Training and Intelligence Division, Office of Chief, Chemical Corps, U.S. Department of the Army. Unclassified. Archived at the U.S. Army Medical Research Institute of Infectious Diseases, Atlanta, Georgia.
22. Cole L.A. Clouds of Secrecy: The Army's Geret Warfare Tests Over Populated Areas 1988, 11-12. Rowman and Littefield, Fort Detrick, MD.
23. st Century 1994, 1-15. Brassey's (UK), Totowa, N.J.
24. Danzig R., Berkowsky P.B. Why shouldire be concerned about biological warfare?. JAMA 1997, 278:431-432.
25. de Paiva A., Meunier F.A., Molgo J., Aoki K.K., Dolly J.O. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 1999, 96:3200-3205.
26. Derbes V.J. De Mussis and the great plague of 1348: A forgotten episode of bacteriological warfare. JAMA 1966, 196:179-182.
27. Dinges M.M., Orwin P.M., Schlievert P.M. Exotoxins from Staphylococcus aureus. Microbiol. Rev. 2000, 13:16-34.
28. Dodds K.L. Restaurant-associated botulism outbreaks in North America. Food Control. 1990, 1:139-141.
29. Dodds K.L. Clostridium botulinum in the environment. Clostridium Botulinum-Ecology and Control in Foods 1992, 21-51. Marcel Dekker Inc., London. A.H.W. Hauschild, K.L. Dodds (Eds.).
30. Dolman C.E., Murakami L. Clostridium botulinum type F with recent observations on other types. J. Infect Dis. 1961, 109:107-128.
31. Ehrenreich H., Garner C.G., Witt T.N. Complete bilateral internal ophthalmoplegia as sole clinical sign of botulism: confirmation of diagnosis by single fibre electromyography. J. Neurol. 1989, 236:243-245.
32. Eitzen E.M., Takafuji E.T. Historical Overview of Biological Warfare. Textbook of Military Medicine, Part I: Warfare, Weaponry, and then Casualty: Medical Aspects of Chemical and Biological Warfare 1997, 415-423. Chapter 18, Borden Institute, Walter Reed Army Medical Center, New York, N.Y. F.R. Slidell, E.T. Takafuji, D.R. Franz (Eds.).
33. Eleopra R., Tugnoli V., Quatrale R., Rossetto O., Montecucco C., De Grandis D. Botulinum neurotoxin serotypes C and E: Clinical trials. Scientific and Therapeutic Aspects of Botulinum Toxin 2002, 441-450. Chapter 42, Lippincott Williams & Wilkins, Washington, D.C. M.E. Brin, M. Hallett, J. Jankovic (Eds.).
34. Falkenrath R.A., Newman R.D., Thayer B.A. America's Achilles Heel: Nuclear, Biological, and Chemical Terrorism and Covert Attack 1998, 167-260. Chapters 3 and 4, The MIT Press, New York, N.Y.
35. Ferguson J.R. Biological weapons and the U.S. law. JAMA 1997, 278:357-360.
36. Fern E.A. Biological warfare in the eighteenth-century North America: beyond Jeffrey Amherst. J. Am. Hist. 2000, 86:1552-1580.
37. Foran P., Mohammed N., Lisk G., Nagwaney S., Lawrence G., Johnson E., Smith L.A., Aoki R., Dolly J.O. Evaluation of the therapeutic usefulness of botulinum neurotoxins B, C1, E, and F compared to the long-lasting type A: basis for distinct durations of inhibition of exocytosis in central neurons. J. Biol. Chem 2003, 278:1363-1371.
38. Franz D.R., Pitt L.M., Clayton M.A., Hanes M.A., Rose K.J. Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism. Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects 1993, 473-476. Plenum Press, Cambridge, MA. B.R. DasGupta (Ed.).
39. Franz D.R. Defense against toxin weapons. Textbook of Military Medicine, Part I: Warfare, Weaponry, and then Casualty: Medical Aspects of Chemical and Biological Warfare 1997, 603-619. Chapter 30, Borden Institute, Walter Reed Army Medical Center, New York, N.Y. F.R. Slidell, E.T. Takafuji, D.R. Franz (Eds.).
40. Franz D.R., Parrott C.D., Takafuji E.T. The U.S. biological warfare and biological defense programs. Textbook of Military Medicine, Part I: Warfare, Weaponry, and then Casualty: Medical Aspects of Chemical and Biological Warfare 1997, 425-436. Chapter 19, Borden Institute, Walter Reed Army Medical Center, Washington, D.C. F.R. Slidell, E.T. Takafuji, D.R. Franz (Eds.).
41. Franz D.R., Jahrling P.B., Friedlander A.M., McClain D.J., Hoover D.L., Byrne W.R., Pavlin J.A., Christopher G.W., Eitzen E.M. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997, 278:399-411.
42. Franz D.R., Zajtchuk Biological terrorism: understanding the threat, preparation, and medical response. Disease-a-Month 2000, 125-192. Mosby, Inc., Washington, D.C. E.E. Brueschke (Ed.).
43. Geissler E. Introduction. Biological and Toxin Weapons Today 1986, 1-20. Chapter 1, Oxford University Press, Stockholm International Peace Research Institute, Linn, MI.
44. Gill D.M. Bacterial toxins: a table of lethal amounts. Microbiol. Rev. 1982, 46:86-94.
45. Gold H. Unit 731 Testimony 1996, YENBOOKS, Oxford, England.
46. Granum P.E., Brynestad S. Bacterial toxins as food poisons. The Comprehensive Sourcebook of Bacterial Protein Toxins 1999, 669-681. Chapter 38, Academic Press, Singapore. J.E. Alouf, J.H. Freer (Eds.).
47. Greenfield R.A., Brown B.R., Hutchins J.B., Iandolo J.J., Jackson R., Slater L.N., Bronze M.S. Microbiological, biological, and chemical weapons of warfare and terrorism. Am. J. Med. Sci. 2002, 323:326-340.
48. Gunnison J.B., Meyer K.F. Susceptibility of monkeys, goats, and small animals to oral administration of botulinum toxin types B, C, and D. J Infect Dis. 1930, 46:335-340.
49. Gurr N., Cole B. The New Face of Terrorism: Threat from Weapons of Mass Destruction 2000, 1-21. I.B. Tauris Publishers, London.
50. Hall J.D., McCroskey L.M., Pincomb B.J., Hatheway C.L. Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol. 1985, 21:654-655.
51. Harris S.H. Factories of Death: Japanese Biological Warfare, 1932-45, and the American Cover-up 1994, Routledge, London.
52. Harris S.H. Japanese biomedical experimentation during the World-War-II era. Military Medical Ethics, Volume II 2003, 463-506. Chapter 16, Borden Institute, Walter Reed Army Medical Center, New York, N.Y. T.E. Beam, L.R. Sparacino (Eds.).
53. Harris R., Paxman J. A Higher Form of Killing 1982, 76-79. Hill and Wang, Washington, D.C.
54. Harris R., Paxman J. A Higher Form of Killing 1982, 153. Hill and Wang, New York, N.Y.
55. Hatheway C.L. Clostridium botulinum and other clostridia that produce botulinum neurotoxins. Clostridium Botulinumecology and Control in Foods 1992, 3-10. Marcel Dekker Inc., New York, N.Y. A.H.W. Hauschild, K.L. Dodds (Eds.).
56. Henderson D.A. The looming threat of bioterrorism. Science 1999, 283:1279-1282.
57. Herrero B.A., Ecklung A.E., Streett C.S., Ford D.F., King J.K. Experimental botulism in monkeys-a clinical pathological study. Exp Mol Pathol 1967, 6:84-95.
58. Hill E.V. Botulism. Summary Report on B. W. Investigations 1947, December 12, 1947; tab D. Archived at the U.S. Library of Congress, Washington, D.C., Memorandum to Alden C. Waitt, Chief Chemical Corps, United States Army, New York, N.Y.
59. Holloway H.C., Norwood A.E., Fullerton C.S., Engel, Ursano R.J. The threat of biological weapons: prophylaxis and mitigation of psychological and social consequences. JAMA 1997, 278:425-427.
60. Holmberg S.D., Blake P.A. Staphylococcal food poisoning in the United States. JAMA 1984, 251:487-489.
61. Hughes J.M., Blumenthal J.R., Merson M.H., Lombard G.L., Dowell V.R., Gangarosa E.J. Clinical features of types A and B food-borne botulism. Ann. Intern. Med. 1981, 95:442-445.
62. Hunter S.E., Clarke I.N., Kelly D.C., Titball R.W. Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli. Infect. Immun. 1992, 60:102-110.
63. Jablonski K.M., Bohach G.A. Staphylococcus aureus. Food Microbiology: Fundamentals and Frontiers 1997, 327-336. ASM Press. M. Doyle, L. Beuchat, T. Montville (Eds.).
64. Johnson H.M., Russell J.K., Pontzer C.H. Superantigens in human disease. Sci Am. 1992, 266:92-101.
65. Kolavic S.A., Kimura A., Simmons S.L., Slutsker L., Barth S., Haley C.E. An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination. JAMA 1997, 278:396-398.
66. Kortepeter M., Parker G.W. Potential biological weapons threats. Emerg. Infect. Dis. 1999, 5:523-527.
67. Krakauer T., Stiles B.G. Staphylococcal enterotoxins, toxic shock syndrome toxin-1, and streptococcal pyrogenic exotoxins: some basic biology of bacterial superantigens. Recent Res. Develop. Infect. Immun. 2000, 1:1-27.
68. Kupperman R.H., Smith D.M. Coping with biological terrorism. Biological Weapons: Weapons of the Future? 1993, 35-46. The Center for Strategic and International Studies, Washington, D.C. B. Roberts (Ed.).
69. Lamanna C. The most poisonous poison. Science 1959, 130:763-772.
70. Landmann G. Ueber die Ursache der darmstadter Bohnenvergiftung. Hyg. Rundschau. 1904, 14:449-452.
71. Lane H.C., LaMontagne J., Fauci A.S. A clear and present danger. Nature Med. 2001, 7:1271-1273.
72. Leuchs J. Beitrage zur Kenntnis des Toxins and Antitoxins des Bacillus botulinus. Z. Hyg. Infektionskrankh 1910, 65:55-84.
73. Lewis K.H., Hill E.V. Practical media and control measurements for producing highly toxic cultures of Clostridium botulinum, type A. J. Bacteriol. 1947, 53:213-230.
74. Malizio C.J., Goodnough M.C., Johnson E.A. Purification of Clostridium botulinum type A neurotoxin. Methods in Molecular Biology, Bacterial Toxins: Methods and Protocols 2000, 27-39. Humana Press, Washington, D.C. O. Holst (Ed.).
75. Mann J.M., Martin S., Hoffman R., Marrazzo S. Patient recovery from type A botulism: morbidity assessment following a large outbreak. Am. J. Public Health 1981, 71:266-269.
76. Maroon J.C. Late effects of botulinum intoxication. JAMA 1977, 238:129.
77. Mattix M.E., Hunt R.E., Wilhelmson C.L., Johnson A.J., Baze W.B. Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol. 1995, 23:262-268.
78. McLaughlin J.B., Sobel J., Lynn T., Funk E., Middaugh J.P. Botulism type E outbreak associated with eating a beached whale, Alaska. Emerg. Infec. Dis. 2004, 10:1685-1687.
79. Mee C. How a mysterious disease laid low Europe's masses. Smithsonian. 1990, 20:66-79.
80. Merson M.H., Dowell V.R. Epidemiologic, clinical, and laboratory aspects of wound botulism. N. Engl. J. Med. 1973, 289:1105-1110.
81. Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Yampolskaya O. The Sverdlovsk anthrax outbreak of 1979. Science 1994, 266:1202-1208.
82. Middlebrook J.L., Franz D.R. Botulinum toxins. Textbook of Military Medicine, Part I: Warfare, Weaponry, and then Casualty: Medical Aspects of Chemical and Biological Warfare 1997, 643-654. Chapter 33, Borden Institute, Walter Reed Army Medical Center, Totowa, New Jersey. F.R. Slidell, E.T. Takafuji, D.R. Franz (Eds.).
83. Miller J. At bleak Asian site, killer germs survive. New York Times 1999, A1. June 2, 1999.
84. Miller J. At bleak Asian site, killer germs survive. New York Times 1999, A10. June 2, 1999.
85. Miller J., Engelberg S., Broad W. Germs: Biological Weapons and America's Secret War 2001, 15-33. Simon and Schuster, Washington, D.C.
86. Miyata S., Matsushita O., Minami J., Katayama S., Shimamoto S., Okabe A. Cleavage of a C terminal peptide is essential for heptamerization of Clostridium perfringens epsilon toxin in the synaptosomal membrane. J. Biol. Chem. 2001, 276:13778-13783.
87. Miyata S., Minami J., Tamai E., Matsushita O., Shimamoto S., Okabe A. Clostridium perfringens epsilon toxin forms a heptameric pore within the detergent-insoluble microdomains of Madin-Darby canine kidney cells and rat synaptosomes. J. Biol. Chem. 2002, 277:39463-39468.
88. Miyamoto O., Minami J., Toyoshima T., Nakamura T., Masada T., Nagao S., Negi T., Itano T., Okabe A. Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system. Infect. Immun. 1998, 66:2501-2508.
89. Miyamoto O., Sumitani K., Nakamura T., Yamagami S., Miyata S., Itano T., Negi T., Okabe A. Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol. Lett. 2000, 189:109-113.
90. Monday S.R., Bohach G.A. Properties of Staphylococcus aureus enterotoxins and toxic shock syndrome toxin-1. The Comprehensive Sourcebook of Bacterial Protein Toxins 1999, 589-610. Chapter 33, Academic Press, New York, N.Y. J.E. Alouf, J.H. Freer (Eds.).
91. Ohishi I. Oral toxicities of Clostridium botulinum type A and B toxins from different strains. Infect. Immun. 1984, 43:487-490.
92. Olsen S.J., MacKinnon L.C., Goulding J.S., Bean N.H., Slutsker L. Surveillance for foodborne-disease outbreaks-United States, 1993-1997. MMWR CDC Surveill Summ 2000, 49:1-62.
93. O'Mahony M., Mitchell E., Gilbert R.J., Hutchinson D.N., Begg N.T., Rodhouse J.C., Morris J.E. An outbreak of food-borne botulism associated with contaminated hazelnut yoghurt. Epidemiol Infect. 1990, 104:389-395.
94. Parkman F. The Conspiracy of Pontiac 1969, 44-46. Little Brown, London.
95. Petit L., Maier E., Gibert M., Popoff M.R., Benz R. Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J. Biol. Chem. 2001, 276:15736-15740.
96. Petit L., Gibert M., Gourch A., Bens M., Vandewalle A., Popoff M.R. Clostridium perfringens epsilon toxin rapidly decreases membrane barrier permeability of polarized MDCK cells. Cell. Microbiol. 2003, 5:155-164.
97. Popoff M.R. Ecology of neurotoxigenic strains of clostridia. Current Topics in Microbiology: Clostridial Neurotoxins The Molecular Pathigenesis of Tetanus and Botulism 1995, 1-29. Springer-Verlag, Boston, Mass. C. Montecucco (Ed.).
98. Poupard J.A., Miller L.A., Granshaw L. The use of small-pox as a biological weapon in the French and Indian War of 1763. ASM News 1989, 55:122-124.
99. Rotz L.D., Khan A.S., Lillibridge S.R., Ostroff S.M., Hughes J.M. Public health assessment of potential biological terrorism agents. JAMA 2002, 8:225-230.
100. Rusnak J.M., Kortepeter M., Ulrich R., Poli M., Boudreau E. Laboratory exposures to Staphylococcal enterotoxin B. Emerg. Infect. Dis. 2004, 10:1544-1549.
101. Schantz E.J., Johnson E.A. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev. 1992, 56:80-99.
102. Schmidt C.F. Spores of C. botulinum: formation, resistance, germination. Botulism: Proceedings of a Symposium 1964, 69-82. U.S. Department of Health, Education, and Welfare, Public Health Service, Berlin. K.H. Lewis, K. Cassel (Eds.).
103. Schuler A. Billions for biodefense: federal agency biodefense funding, FY2001-FY2005. Biosecurity Bioterrorism 2004, 2:86-96.
104. Scott A.B., Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov. Disord. 1988, 333-335.
105. Shaffer N., Wainwright R.B., Middaugh J.P., Tauxe R.V. Botulism among Alaska natives. The role of changing food preparation and consumption practices. West J. Med. 1990, 153:390-393.
106. Shaffer D., Armstrong G., Higgins K., Honig P., Coyne P., Boxwell D., Beitz J., Leissa B., Murphy D. Increased U.S. prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign. Pharmacoepidemiol. Drug. Saf. 2003, 12:177-182.
107. Shone C.C., Tranter H.S. Growth of clostridia and preparation of their neurotoxins. Current Topics in Microbiology: Clostridial Neurotoxins: The Molecular Pathigenesis of Tetanus and Botulism 1995, 143-160. Springer-Verlag, Cincinnati, Ohio. C. Montecucco (Ed.).
108. Siegel L.S., Metzger J.F. Toxin production by Clostridium botulinum type A under various fermentation conditions. Appl. Environ. Microbiol. 1979, 38:606-611.
109. Simpson L.L. Identification of the major steps in botulinum toxin action. Ann. Rev. Pharmacol. Toxicol. 2004, 44:167-193.
110. Skjelkvale R., Uemura T. Experimental diarrhea in human volunteers following oral administration of Clostridium perfringens enterotoxin. J. Appl. Bacteriol. 1977, 43:281-286.
111. Smart J.L., Roberts T.A., McCullagh K.G., Lucke V.M., Pearson H. An outbreak of type C botulism in captive monkeys. Vet. Rec. 1980, 107:445-446.
112. Smart J.L., Jones T.O., Clegg F.G., McMurray M.J. Poultry waste associated type C botulism in cattle. Epidemiol. Inf. 1987, 98:73-79.
113. Smedley J.G., Fisher D.J., Sayeed S., Chakrabarti G., McClane B.A. The enteric toxins of Clostridium perfringens. Rev. Physiol. Biochem. Pharmacol. 2004, 152:183-204.
114. Smith L.D.S. The occurence of Clostridium botulinum and Clostridium tetani in the soil of the United States. Health Lab Sci 1978, 15:74-80.
115. Sobel J., Tucker N., Sulka A., McLaughlin J., Maslanka S. Foodborne botulism in the United States, 1900-2000. Emerg. Infect. Dis. 2004, 10:1606-1611.
116. Songer J.G. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 1996, 9:216-234.
117. Stearn E.W., Stearn A.E. The Effects of Smallpox on the Destiny of the Amerindians 1945, 44-45. Bruce Humphries, Berlin.
118. Stephenson J. Pentagon-funded research takes aim at agents of biological warfare. JAMA 1997, 278:373-375.
119. Sugishima M. Aum Shinrikyo and the Japanese law on bioterrorism. Prehosp. Disas. Med. 2003, 18:179-183.
120. Sugiyama H. Clostridium botulinum neurotoxin. Microbiol Rev. 1980, 44:419-448.
121. st century. Textbook of Military Medicine, Part I: Warfare, Weaponry, and then Casualty: Medical Aspects of Chemical and Biological Warfare 1997, 677-685. Chapter 35, Borden Institute, Walter Reed Army Medical Center, Boston, MA. F.R. Slidell, E.T. Takafuji, D.R. Franz (Eds.).
122. Tamai E., Ishida T., Miyata S., Matsushita O., Suda H., Kobayashi S., Sonobe H., Okabe A. Accumulation of Clostridium perfringens epsilon toxin in the mouse kidney and its possible biological significance. Infect. Immun. 2003, 71:5371-5375.
123. Torok T.J., Tauxe R.V., Wise R.P., Livengood J.R., Sokolow R., Mauvais S., Birkness K.A., Skeels M.R., Horan J.M., Foster L.R. A large community outbreak of Salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 1997, 278:389-395.
124. Tranter H.S. Foodborne staphylcoccal illness. Lancet 1990, 336:1044-1046.
125. Tucker J. National response and medical services response to incidents of chemical and biological terrorism. JAMA 1997, 278:362-368.
126. Ulrich R.G. Evolving superantigens of Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 2000, 27:1-7.
127. Ulrich R.G., Bavari S., Olson M.A. Bacterial superantigens in human disease: structure, function, and diversity. Trends Microbiol. 1995, 3:463-468.
128. Ulrich R.G., Sidell S., Taylor T.J., Wilhelmsen C.L., Franz D.R. Staphylococcal enterotoxin B and related pyrogenic toxins. Textbook of Military Medicine, Part I: Warfare, Weaponry, and then Casualty: Medical Aspects of Chemical and Biological Warfare 1997, 621-630. Chapter 31, Borden Institute, Walter Reed Army Medical Center, Washington, D.C. F.R. Slidell, E.T. Takafuji, D.R. Franz (Eds.).
129. United Nations Security Council Tenth Report of the Executive Chairman of the Special Commission Established by the Secretary-General Pursuant to Paragraph 9(b)(I) of Security Council Resolution 687 (1991), and Paragraph 3 of Resolution 699 (1991) on the Activities of the Special Commission 1995, S/1995/1038, United Nations Security Council, Wasington, D.C.
130. van Ermengen E. Ueber einen neuren anaeroben Bacillus und seine beziehungen zum botilismus. Z. Hyg. Infektionskrankh. 1897, 26:1-56.
131. Varma J.K., Katsitadze G., Moiscrafishvili M., Zardiashvili T., Chokheli N., Jhorjholiani E., Chubinidze M., Kukhalashvili T., Kkmaladze I., Chakvetadze N., Imnagze P., Sobel J. Foodborne botulism in the Republic of Georgia. Emerg. Infect. Dis. 2004, 10:1601-1605.
132. Ward B.Q., Carroll B.J., Garrett E.S., Reese G.B. Survey of the U.S. Gulf coast for the presence of Clostridium botulinum. Appl Microbiol. 1967, 15:629-636.
133. Warner R. Thucydides, The History of the Peloponnesian War, 431 B.C.E. 1972, Viking Press, New York, N.Y.
134. Wheelis M. Biological warfare before 1914. Biological and Toxin Weapons: Research, Development, and Use from the Middle Ages to 1945 1999, 21-24. Oxford University Press for the Stockholm International Peace Research Institute, New York, N.Y. E. Geissler, J.E. van Courtland Moon (Eds.).
135. Whitlock R.H., Buckley C. Botulism. Vet. Clin. N. Amer. Eq. Proc. 1997, 13:107-128.
136. Wilkening D.A. BCW attack scenarios. The New Terror: Facing the Threat of Biological and Chemical Weapons 2000, 76-114. Hoover Institution Press, Stanford University, Oxford, England. S.D. Drell, A.D. Sofaer, G.D. Wilson (Eds.).
137. Williams P., Wallace D. Unit 731: Japan's Secret Biological Warfare in World War II 1989, The Free Press, Stanford, CA.
138. Wilson R., Morris J.G., Snyder J.D., Feldman R.A. Clinical characteristics of infant botulism in the United States: a study of the non-California cases. Pediatr. Infect. Dis. 1982, 1:148-150.
139. Wright S. Evolution of biological warfare policy, 1945-1990. Preventing a Biological Arms Race 1990, 26-68. Chapter 2, The MIT Press, New York, N.Y. S. Wright (Ed.).
140. Zapor M., Fishbain J.T. Aerosolized biologic toxins as agents of warfare and terrorism. Respir. Care Clin. 2004, 10:111-122.
141. Zilinskas R.A. Iraq's biological weapons: the past and future?. JAMA 1997, 278:418-424.